Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment

被引：0
|
作者：
Arnold Bolomsky
Karin Schlangen
Wolfgang Schreiner
Niklas Zojer
Heinz Ludwig
机构：
[1] Department of Medicine I,Wilhelminen Cancer Research Institute
[2] Wilhelminenspital,Center for Medical Statistics, Informatics and Intelligent Systems
[3] Medical University of Vienna,undefined
来源：
Journal of Hematology & Oncology | / 9卷
关键词：
Multiple myeloma; BMI-1; PTC-209; Microenvironment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 36 条
  • [31] Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
    Elisa Taiana
    Vanessa Favasuli
    Domenica Ronchetti
    Katia Todoerti
    Francesca Pelizzoni
    Martina Manzoni
    Marzia Barbieri
    Sonia Fabris
    Ilaria Silvestris
    Maria Eugenia Gallo Cantafio
    Natalia Platonova
    Valeria Zuccalà
    Lorenza Maltese
    Debora Soncini
    Samantha Ruberti
    Michele Cea
    Raffaella Chiaramonte
    Nicola Amodio
    Pierfrancesco Tassone
    Luca Agnelli
    Antonino Neri
    Leukemia, 2020, 34 : 234 - 244
  • [32] A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo.
    Peipp, Matthias
    Gramatzki, Martin
    Burger, Renate
    Klausz, Katja
    Kellner, Christian
    Guenther, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] P-BCMA-ALLO1-A Fully Allogeneic Stem Cell Memory T Cell (TSCM) CAR-T Therapy Targeting BCMA for the Treatment of Multiple Myeloma Shows Potent Anti-Tumor Activity
    Richter, Maximilian
    Cranert, Stacey
    Patil, Deepak
    Zhang, Yan
    Tan, Yening
    Tong, Min
    Domingo, Christine
    Weiss, Leslie
    Marquez, Karl
    Sparks, Jessica
    Argus, Elvira
    Martin, Christopher
    Ostertag, Eric
    Jain, Sumiti
    Coronella, Julia
    Shedlock, Devon
    MOLECULAR THERAPY, 2021, 29 (04) : 382 - 383
  • [34] Targeting Distinct Epitopes of FCRL5 Using CAR-T Generated with Sequences Derived from Newly Identified FCRL5 Humanized Antibodies Resulted in Potent Anti-Myeloma Activity in Vitro and In Vivo
    O'Neal, Julie
    Ritchey, Julie K.
    Gladney, Susan
    Haas, Gabriel J.
    Abboud, Ramzi
    Rettig, Michael P.
    Bruges, Cedric
    Eissenberg, Linda
    DiPersio, John F.
    BLOOD, 2023, 142
  • [35] The novel ICAM-1/CD54 antibody MSH-TP15, identified by a cell-based phage display screening approach, has potent anti-myeloma activity in vitro and in vivo
    Klausz, K.
    Burger, R.
    Kellner, C.
    Peipp, M.
    Gramatzki, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 201 - 201
  • [36] GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors
    Lee, Y
    Vassilakos, A
    Feng, NP
    Jin, HN
    Wang, M
    Xiong, K
    Wright, J
    Young, AP
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (02) : 469 - 478
1234